Related Experiment Video
Updated: Aug 12, 2025

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.8K
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration
Keiko Akagi1, David E Symer2, Medhat Mahmoud3
1Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Discovery
|January 30, 2023
Summary
Human papillomavirus (HPV) integration causes a novel genomic variation called heterocateny. This process drives cancer evolution by rearranging host DNA and increasing tumor diversity.
Area of Science:
- Genomics
- Cancer Biology
- Virology
Background:
- Human papillomavirus (HPV) integration into host DNA is common in HPV-positive cancers.
- The impact of HPV integration on chromosomal integrity remains largely unknown.
- Understanding these genomic alterations is crucial for cancer research.
Purpose of the Study:
- To investigate the consequences of HPV genome integration on host DNA.
- To identify and characterize novel forms of structural variation in HPV-positive cancers.
- To elucidate the role of these variations in tumor evolution and heterogeneity.
Main Methods:
- Utilized continuous long-read sequencing on oropharyngeal cancer samples and cell lines.
- Analyzed structural variations, focusing on repetitive patterns of viral and host DNA concatemers.
- Reconstructed the evolutionary pathways of structural variants using shared breakpoints.
Main Results:
- Identified a new structural variation termed "heterocateny," characterized by diverse, interrelated concatemers of HPV and host DNA.
- Demonstrated that virus-host concatemers are unstable, facilitating host DNA capture, amplification, and recombination.
- Observed heterocateny in both extrachromosomal and intrachromosomal DNA within tumors.
Conclusions:
- Heterocateny is driven by aberrant replication and recombination of oncogenic HPV DNA.
- This process promotes intratumoral heterogeneity and clonal evolution in HPV-positive cancers.
- Extends the known consequences of HPV integration beyond simple DNA insertion.
Related Concept Videos
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancers Originate from Somatic Mutations in a Single Cell
12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer
49.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.0K

